Shun Takaku

A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

Masaki Terabe, Jeremy B. Swann, Elena Ambrosino et al. · The Journal of Experimental Medicine · 2005 · 279 citations · Full text

Life Sciences, Immunology, Oncology +17

Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis

Elena Ambrosino, Masaki Terabe, Ramesh Halder et al. · The Journal of Immunology · 2007 · 205 citations · Full text

Life Sciences, Immunology, Oncology +12

Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody

Masaki Terabe, Elena Ambrosino, Shun Takaku et al. · Clinical Cancer Research · 2009 · 112 citations · Full text

Life Sciences, Immunology, Oncology +13

Blockade of TGF‐β enhances tumor vaccine efficacy mediated by CD8⁺ T cells

Shun Takaku, Masaki Terabe, Elena Ambrosino et al. · International Journal of Cancer · 2009 · 82 citations · Full text

Medicine, Immunology, Oncology +17

Induction of hepatic injury by hepatitis C virus-specific CD8+ murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes

Shun Takaku, Yohko Nakagawa, Masumi Shimizu et al. · Biochemical and Biophysical Research Communications · 2003 · 32 citations

Medicine, Immunology, Pathology +16